Medicare Enrolled

Dr. Martin Berk, M.D.

Cardiovascular Disease · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
7150 GREENVILLE AVE STE 500, Dallas, TX 75231
2143693613
In practice since 2005 (20 years)
NPI: 1033118278 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Berk

Dr. Martin Berk is a cardiovascular disease in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Berk performed 4,488 Medicare services across 2,862 unique beneficiaries.

Between the years covered by Open Payments, Dr. Berk received a total of $402,973 from 29 pharmaceutical and/or device companies across 429 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Berk is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 20% volume in TX$ $402,973 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,488
Medicare services
Top 20% in TX for cardiovascular disease
2,862
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~224 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Electrocardiogram (EKG), 12-lead1,235$10$65
Office visit, established patient (30-39 min)1,147$86$323
EKG interpretation and report543$6$28
Hospital follow-up visit, moderate complexity213$62$238
Heart muscle strain imaging180$29$103
Office visit, established patient, complex (40-54 min)173$132$435
Echocardiogram, transthoracic144$144$734
Hospital follow-up visit, high complexity133$94$342
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report86$173$781
Ultrasound of both sides of head and neck blood flow86$133$789
Ultrasound of heart blood flow, valves and chambers84$40$241
Ultrasound of heart with color-depicted blood flow, rate and valve function84$19$222
New patient office visit, complex (60-74 min)74$150$622
Ultrasound of heart with probe in esophagus, with report51$83$281
Initial hospital admission, high complexity45$133$670
Ultrasound scan of abdominal aorta40$70$71
Transitional care management services for problem of high complexity40$211$734
External shock to heart to regulate heart beat29$85$806
Initial hospital admission, moderate complexity23$93$455
Hospital follow-up visit, low complexity23$35$129
Transitional care management services for problem of at least moderate complexity16$152$520
Office visit, established patient (20-29 min)14$50$218
Test to determine lung volumes using sensors13$9$171
Ultrasound of leg arteries or artery grafts12$188$997
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
10.1% medium
82.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$402,973
Total received (2018-2024)
Avg $57,568/year across 7 years
Top 1% in TX for cardiovascular disease
29
Companies
429
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$395,154 (98.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,693 (1.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,126 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$94,651
2023
$49,394
2022
$76,527
2021
$21,361
2020
$20,308
2019
$73,457
2018
$67,275

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$154,422
Novo Nordisk Inc
$83,590
Merck Sharp & Dohme LLC
$82,115
Novartis Pharmaceuticals Corporation
$31,031
Boehringer Ingelheim Pharmaceuticals, Inc.
$27,572
Lilly USA, LLC
$8,877
Regeneron Healthcare Solutions, Inc.
$6,333
Esperion Therapeutics, Inc.
$5,938
Boston Scientific Corporation
$813
Amgen Inc.
$449
Abbott Laboratories
$309
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$295
HeartFlow, Inc.
$263
Inspire Medical Systems, Inc.
$145
Amarin Pharma Inc.
$138
BOSTON SCIENTIFIC CORPORATION
$122
IDORSIA PHARMACEUTICALS US INC
$121
PFIZER INC.
$78
SANOFI-AVENTIS U.S. LLC
$76
E.R. Squibb & Sons, L.L.C.
$74
Bard Peripheral Vascular, Inc.
$42
Siemens Medical Solutions USA, Inc.
$32
Itamar Medical Inc
$30
Lexicon Pharmaceuticals, Inc.
$23
Astellas Pharma US Inc
$22
Kiniksa Pharmaceuticals International, plc
$19
SCPHARMACEUTICALS INC.
$19
AstraZeneca Pharmaceuticals LP
$14
Gilead Sciences, Inc.
$11
Top 3 companies account for 79.4% of total payments
Associated products mentioned in payments ›
ACCOLADE · Arcalyst · Artis Q · CAMZYOS · Corlanor · DYNAGEN · ELIQUIS · EMBLEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · FARXIGA · FFRct · FUROSCIX · GENERAL TACHY · GENERAL THERAPIES · GENERAL THERAPIES · INGEVITY · INSPIRE · JARDIANCE · LATITUDE · LEQVIO · LEXISCAN · LUTONIX Drug Coated Balloon · LifeVest · MULTAQ · Mitra Clip system · NEXLETOL · NEXLIZET · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Rybelsus · SC2000 · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Tryvio · VERQUVO · VIGILANT · VYNDAMAX · Vascepa · Victoza · WATCHMAN · WatchPAT · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in TX.

Equivalent to $8,979 per 100 Medicare services performed
Looking for a cardiovascular disease in Dallas?
Compare cardiovascular diseases in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
306
Per 100K population
11.8
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Berk is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Berk experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Berk performed 1,235 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berk receive payments from pharmaceutical companies?
Yes. Dr. Berk received a total of $402,973 from 29 companies across 429 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berk's costs compare to other cardiovascular diseases in Dallas?
Dr. Berk's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →